News Releases

Using click-release proteolysis targeting chimeras, researchers have developed a new method of activating specific molecules to target cancer cells without harming healthy cells.

A new study found that the combination of chronic pain and anxiety or depression affects more than 12 million adults in the U.S.

Comprehensive Pain and Addiction Center researchers surveyed teens on both sides of the U.S.-Mexico border and found that strong family support can prevent children from using alcohol or drugs.

Two Arizona medical students have established a research platform that aims to facilitate global collaboration.

A renowned diagnostic radiologist, Dr. Frank Rybicki specializes in cardiovascular imaging and 3D printing.

University of Arizona Health Sciences researchers will continue their study of green light therapy, a promising non-opioid pain relief option.

The Aegis Consortium awarded seed funding to eight projects that align with the UArizona Health Sciences center’s mission to create a pandemic-free future.

Students in their final year of medical school received the academic merit-based scholarship.

Academic researchers and industry professionals will discuss drug development at the Fifth Annual Arizona Drug Discovery and Development Summit.

The new molecules exploit the iron dependency of malignant cells and could lead to the development of new anticancer drugs.